Why the name Mochi?
Mochi—a bite size dessert—signifies the small moments of joy in life.

It’s a reminder to live today, that no matter where you are in your journey, whether that involves weight loss or not, that we should center ourselves around what is good & use that as fuel to build towards the tomorrow of our dreams.
Our Mission

Healthcare has a history of blaming weight as some type of moral failing on the patient.

We listen. Our mission is to make our patients feel heard and understood. We connect our providers with patients to discuss evidence-based weight loss strategies using every tool in our belt: Licensed RDNs, MDs who are Board Certified in Obesity Medicine, CBT-i for sleep therapy, and prescription medication. We customize treatment approaches based on eligibility form responses to provide the best results. Customizable treatment, that best suits your weight-loss needs.
Emotes
Myra Ahmad
Developed by real doctors
Meet Our Founder

Between research and medical school, I had chosen to commit my life to helping the most vulnerable patients. I wanted to provide accessible care for communities traditionally ignored by healthcare: those without insurance, those facing language and cultural barriers, or those in rural communities.

joinmochi.com $40 off your first order

{{{ Website: https://joinmochi.com }}}

{{{ Coupon Code: 763HJB }}}

Despite having learned about comprehensive weight loss strategies used by bariatric surgery practices and obesity medicine providers, I rarely saw these recommended. More often, I saw providers use shame when discussing a patient’s hypertension, dismiss other medical concerns due to bias, and refuse to use safe and affordable medications in favor of “diet and exercise only” strategies. These providers didn’t see the value in listening to patients.

What excites me most about Mochi is we connect providers with patients to discuss evidence-based weight loss strategies using every tool in our belt: Licensed RDNs, MDs who are Board Certified in Obesity Medicine, CBT-i for sleep therapy, and prescription medication. We customize treatment approaches based on eligibility form responses to provide the best results.

A plan that works for you

Let’s get the conversation started. Whether you have commercial insurance or are uninsured, we have your back here at Mochi Health. 95% of our users stay on for another month after signing up.

Medications

At Mochi we believe in an obesity medicine program that is personalized to you. Science-backed medications (including GLP-1s like Ozempic and Mounjaro / Zepbound and versions of them from compounded pharmacies) are just one tool in our toolbox.

Wondering how to get started? It’s as easy as 1-2-3!
Form icon
Complete eligibility form

Take a few minutes to fill out the form and see if you’re eligible for the program
Get started
Choose subscription icon
Choose a subscription plan

Explore flexible plan options and select one that best suits your needs and goals
Physician icon
Meet your provider and registered dietitian

Set up your profile and schedule a virtual video visit with an obesity medicine provider
Young urban Asian girl talking with laptop video chat gesturing and sitting
You deserve doctors that listen.

Welcome to Mochi, your provider for comprehensive obesity medicine. We’re glad you’re here. Our board certified obesity medicine providers and registered dietitians are ready to work with you through video visits to build a plan that fits your goals.
Our Program
Phase One

Meet your provider to make a plan
Get started on medications¹
Discuss genetic testing for obesity with your provider

¹ May include insurance authorization. If your insurance denies, we have backup options! Visit the medications page.
Phase Two

Establish a baseline for monitoring
Labs and scans as necessary
Discuss with your provider and make adjustments
Check in with your registered dietitian

Phase Three

Continue with your provider and registered dietitian
Make adjustments to your treatment plan as needed

Phase Four

Recheck your laboratory studies
Discuss your progress and plans for maintenance

Why the name Mochi?
Mochi—a bite size dessert—signifies the small moments of joy in life.

It’s a reminder to live today, that no matter where you are in your journey, whether that involves obesity or not, that we should center ourselves around what is good & use that as fuel to build towards the tomorrow of our dreams.

Mochi Health is developed by real doctors committed to helping you. Complete our eligibility form today!

List of Medications

Our Mochi doctors prescribe the most effective and appropriate medication for our patients. We provide all options from GLP-1’s to generic medication. Read over what medications we prescribe below!

Description

Topiramate, a medication originally created to treat epilepsy, was approved by the FDA in 1998. It is used off-label for weight loss, often in conjunction with Phentermine. It can be used short- or long-term for weight loss safely.

ALSO KNOWN AS: Topiramate

AVOID WHEN: History of Kidney Stones; Pregnant; Breastfeeding; Trying to Conceive; History of Anorexia/Bulimia

SIDE EFFECTS: Dizziness (<1%); Paresthesias (5%); Anxiety (1.1%); Headache (1.7%)
How it Works

Topiramate alters a variety of GABA and Glutamate channels in the brain to suppress cravings and appetite.
Expected Results

Topiramate has independently shown results in meta-analysis of 5.34kg weight loss (95% CI 4.56-6.12kg). In conjunction with Phentermine, the CONQUER and SEQUEL Trials Showed as high as 10.7% weight loss in low-dose and 14% in high-dose groups maintained over 2 years.

Description

Bupropion was initially approved as a medication for anxiety and depression. It is also used as a smoking cessation aid, as it reduces cravings and alters mood. It is prescribed off-label either alone or with Naltrexone for weight loss, and also as a combo pill (Contrave).

ALSO KNOWN AS: Wellbutrin XL, Wellbutrin SR, Forfivo XL, Bupropion

AVOID WHEN: History of Bipolar Disorder; Schizophrenia; Hypertension; Concurrent substance use disorder

SIDE EFFECTS: Activation of mania in bipolar patients (<1%); Insomnia (11-40%)
How it Works

Bupropion works by inhibiting neurotransmitter reuptake of norepinephrine and dopamine. By holding higher concentrations of these in the brain, neurons increase signaling and alter hunger and mood.
Expected Results

Bupropion has been studied extensively, both independently and in conjunction with Naltrexone (Contrave). The COR-I, COR-II, COR-BMOD, and COR-Diabetes trials demonstrated 8.1-11.5% weight loss over 2 years.

Description

Naltrexone was developed as a medication for alcohol and substance use disorder. However, as its mechanism is to stop cravings, it has long been prescribed for weight loss. It is a component in the combination pill, Contrave.

ALSO KNOWN AS: Naltrexone

AVOID WHEN: History of Anorexia/Bulimia; Concurrent substance use disorder; Use of opiates; Pregnant; Breastfeeding; Trying to conceive

SIDE EFFECTS: Abdominal Pain (11%); Anxiety (12%); Headache (25%)
How it Works

Naltrexone is a mu-receptor antagonist (blocker). This inhibits the effects on the hypothalamic-pituitary-adrenal axis from this receptor, and thus suppresses appetite and cravings.
Expected Results

Naltrexone has been studied both independently and as a component in Contrave (8.1-11.5% weight loss when used with Bupropion).

Description

Orlistat is a pancreatic lipase inhibitor that was created to block intestinal absorption of fat. It was created for the indication of weight loss, and FDA approved in 1999.

ALSO KNOWN AS: Orlistat

AVOID WHEN: Chronic malabsorption; Pregnancy; Cholestasis/History of Gallbladder disease

SIDE EFFECTS: Oily Spotting (26%); Flatus with Discharge (23.9%); Fecal Urgency (22.1%); Fatty/Oily Stool (20.0%); Oily Evacuation (11.9%); Increased risk of Vitamin D, E, A, K deficiency
How it Works

Orlistat works directly as a lipase inhibitor. By blocking the breakdown of fats in the intestines, fats cannot be absorbed and are excreted in stool.
Expected Results

Orlistat is associated with a modest reduction in weight: meta-analysis including 11 randomized control trials using 120mg of Orlistat 3 times per day showed 2.9% greater weight loss than placebo.

Description

Semaglutide is a GLP-1 agonist created for Type 2 Diabetes and FDA approved in 2019. It was approved for the indication of weight loss as Wegovy in June 2021.

ALSO KNOWN AS: Semaglutide

AVOID WHEN: History of Thyroid C-cell tumors; Pregnant; Breastfeeding; Trying to conceive; History of anorexia/bulimia

SIDE EFFECTS: Nausea (44%); Vomiting (25%); Diarrhea/GI distress (30%)
How it Works

GLP-1 works to increase insulin levels by activating cells in the pancreas. It also triggers hormone release to delay the emptying of the stomach, sometimes causing nausea.
Expected Results

When used alongside robust lifestyle management (200 min exercise/week, nutri-system diet, bimonthly nutritionist visits) patients observed 10-14% weight loss, maintained over 2 years (STEP3 Trial, Novo Nordisk).

Description

Liraglutide is a GLP-1 agonist medication, very similar to Semaglutide. It was initially developed as a medication for Type 2 Diabetes, but found to also help patients with weight loss! By activating GLP-1 receptors, this medication works to slow the rate at which your stomach empties, and to send signals to your brain to decrease appetite.

ALSO KNOWN AS: Liraglutide

AVOID WHEN: Pancreatitis Gallstones; Family history of Thyroid Cancer; Thyroid disorders

SIDE EFFECTS: Nausea (44%); Vomiting (25%); Diarrhea/GI distress (30%)
How it Works

GLP-1 works to increase insulin levels by activating cells in the pancreas. It also triggers hormone release to delay the emptying of the stomach, sometimes causing nausea.
Expected Results

The SCALE Trial showed patients can lose 6.2% over 52 weeks (CI 7.5 to 4.6%).

Description

Tirzepatide is the newest form of weight loss medication. It was recently approved for Type 2 diabetes, and works through both the GLP-1 receptor and GIP receptors. Both of these work to slow stomach emptying and decrease appetite.

ALSO KNOWN AS: Tirzepatide

AVOID WHEN: Chronic malabsorption; Pregnancy; Cholestasis/History of Gallbladder disease; Pancreatitis; Family history of Thyroid Cancer; Thyroid disorders

SIDE EFFECTS: Nausea (44%); Vomiting (25%); Diarrhea/GI distress (30%)
How it Works

Both GLP-1 and GIP receptors work to decrease the rate your stomach empties– keeping you full for longer! They also work to decrease your appetite and cravings.
Expected Results

The SURMOUNT-1 trial showed expected weight loss of 22.5%. Additional trials have shown this medication is twice as effective as Semaglutide 1.0mg.